BackAdagene Overview
Adagene Inc - ADR

Adagene Target Price

Analysts' average 12-month price target for Adagene is $10.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.69

Average Target Price

$10.00171% upside

1 analysts in the last 4 months

High: $10 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-14GuggenheimPaul Jeng$10171% upsideOpen
2024-09-19H.C. WainwrightArthur He$535.5% upsideOpen
2024-04-08Morgan StanleyMatthew Harrison$535.5% upsideOpen

Adagene (ADAG) FAQ

Adagene posts a target price of $10. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $10 for ADAG means covering analysts, on average, see the stock 171.0% upside of $3.69 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ADAG's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Adagene's other metric pages and overview cover the third.

Judging Adagene against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $10 here, then scan peer and history charts to see if the gap is persistent.